Next Course Dates
October 23 - October 25, 2019, Boston, MA
Course Director : Duane B. Lakings, Ph.D.
Duane B. Lakings, Ph.D., is the Principal and President of Drug Safety Evaluation Consulting, Inc... Read More >
Course Description
Course runs 9:00 - 5:00 on Day 1 & Day 2 -- 9:00 - 3:00 on Day 3 (Breakfast & Lunch Included)

This pharmaceutical manufacturing training course will assist pharmaceutical, biotechnology, and CRO researchers and managers in understanding the requirements for a well-designed and successful ADME, PK/TK, and DM program conducted within a drug development logic plan and in compliance with ICH guidelines. 
Learning Objectives
Upon completing this course, participants will have a basic knowledge of the research studies conducted to characterize the likelihood of success for a drug candidate (either a small organic molecule (NCE) or macromolecule) after administration to animal models and humans.
Next Course Dates
October 23 - October 25, 2019, Boston, MA
Course Director : Kenneth Cleaver, Ph.D.
Dr. Kenneth Cleaver is a highly regarded GLP consultant with over 20 years of industry experience. . Read More >
Course Description
Course runs 9:00 - 5:00 on Day 1 & Day 2 -- 9:00 - 3:00 on Day 3 (Breakfast & Lunch Included)

This course will provide participants with a comprehensive understanding of the terminology , regulations and mandated practices for GLP testing and compliance.
Learning Objectives
By the end of this three-day course, attendees will have a strong understanding of the fundamental compliance requirements for current Good Laboratory Practice s, and will be able to apply compliance protocols in all efforts aimed at generating regulated data for evaluation by the US FDA, USEPA and regulatory agencies overseas.
Next Course Dates
October 24 - October 25, 2019, Boston, MA
Course Director : Glenda  Guest
Glenda Guest is Vice President of Norwich Clinical Research Associates Ltd (NCRA). . Read More >
Course Description
Course runs 9:00 to 5:00 both days ( Breakfast & Lunch Included )

This GCP training course provides a solid understanding of GCP requirements and clinical quality assurance in detecting fraud and misconduct in clinical trials. Attendees will gain experience in detecting, correcting, and preventing clinical study misconduct and fraud at domestic and international clinical sites.
Learning Objectives
Upon completion, attendees will be able to:
  • Identify and define the principles and requirements for GCPs
  • Define the basic roles and responsibilities of the sponsor, monitor, investigators and FDA as they relate to the quality of clinical trials
Ready To Become Certified In Pharma/Biotech ?
The Center for Professional Innovation & Education
Website | 1-610-648-7550 | Contact